HYD LLC. is a research-driven biotechnology company focused on the investigation and therapeutic potential of deuterium depletion (DD). As the first organisation worldwide to explore the biological role and physiological significance of naturally occurring deuterium, the company has played a pioneering role in advancing this field of science. Building on decades of research, HYD LLC. continues to develop innovative pharmaceutical and health applications based on DD, with the mission of expanding scientific understanding for preventative health and leading to new approaches in oncology and…
Annual Revenue$10M to $25M
Estimated OwnershipPrivateBuilt from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Matching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.